251 related articles for article (PubMed ID: 1773044)
1. The structure and function of MHC molecules. Possible implications for the control of tumor growth by MHC-restricted T cells.
Kourilsky P; Jaulin C; Ley V
Semin Cancer Biol; 1991 Oct; 2(5):275-82. PubMed ID: 1773044
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte therapy of cancer and tumor escape mechanisms.
Melief CJ; Kast WM
Semin Cancer Biol; 1991 Oct; 2(5):347-54. PubMed ID: 1773050
[TBL] [Abstract][Full Text] [Related]
3. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
5. Commentary: Immune escape versus tumor tolerance: how do tumors evade immune surveillance?
Salih HR; Nüssler V
Eur J Med Res; 2001 Aug; 6(8):323-32. PubMed ID: 11549514
[TBL] [Abstract][Full Text] [Related]
6. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
Yamazaki K; Spruill G; Rhoderick J; Spielman J; Savaraj N; Podack ER
Cancer Res; 1999 Sep; 59(18):4642-50. PubMed ID: 10493519
[TBL] [Abstract][Full Text] [Related]
7. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
[TBL] [Abstract][Full Text] [Related]
8. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
9. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
[No Abstract] [Full Text] [Related]
10. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
11. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
Kim CJ; Parkinson DR; Marincola F
J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
[TBL] [Abstract][Full Text] [Related]
12. Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
Peiper M; Goedegebuure PS; Alldinger I; Knoefel WT; Izbicki JR; Eberlein TJ
Anticancer Res; 2002; 22(6A):3357-63. PubMed ID: 12530087
[TBL] [Abstract][Full Text] [Related]
13. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway.
Rötzschke O; Falk K
Immunol Today; 1991 Dec; 12(12):447-55. PubMed ID: 1723878
[TBL] [Abstract][Full Text] [Related]
14. Influence of major histocompatibility complex class I, class II and TLA genes on tumor rejection.
Ostrand-Rosenberg S; Garcia EP; Roby CA; Clements VK
Semin Cancer Biol; 1991 Oct; 2(5):311-9. PubMed ID: 1773047
[TBL] [Abstract][Full Text] [Related]
15. MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
Ward PL; Schreiber H
Semin Cancer Biol; 1991 Oct; 2(5):321-8. PubMed ID: 1837738
[TBL] [Abstract][Full Text] [Related]
16. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
[TBL] [Abstract][Full Text] [Related]
17. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
Claverie JM; Kourilsky P
Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
[TBL] [Abstract][Full Text] [Related]
18. Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function.
Giuntoli RL; Lu J; Kobayashi H; Kennedy R; Celis E
Clin Cancer Res; 2002 Mar; 8(3):922-31. PubMed ID: 11895927
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
20. Modulation of immunological synapse by membrane-bound and soluble ligands.
González PA; Carreño LJ; Figueroa CA; Kalergis AM
Cytokine Growth Factor Rev; 2007; 18(1-2):19-31. PubMed ID: 17344089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
